SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biocircuits BIOC
BIOC 0.435-13.1%Oct 24 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Xingbo Wang who wrote (34)6/30/1997 6:47:00 PM
From: Steve Robinett   of 65
 
I was obviously joking about the percentage gain. At 13/16 I'm just treading water. On a serious note, I find the Beckton Dickenson deal promising. Assuming it goes through, BIOC just solved two of its problems, manufacturing reliability and sales, leaving them free to expand the assay menu with more tests. Also assuming they can get past the second tranche of their financing deal in July, which has a buy-in price of $1/shr, they might have an extra year to try to survive. Sorry about your 6 buck basis. All things considered, it will probably be a while before BIOC sees 6 again.
Best,
Steve
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext